Viking Therapeutics, Inc. (VKTX)
28.50
+0.77
(+2.78%)
USD |
NASDAQ |
Oct 09, 15:22
Viking Therapeutics 30-Day Average Daily Volume : 6.711M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 6.711M |
| October 07, 2026 | 6.458M |
| October 06, 2026 | 6.348M |
| October 05, 2026 | 6.169M |
| October 02, 2026 | 6.010M |
| October 01, 2026 | 5.854M |
| September 30, 2026 | 5.715M |
| September 29, 2026 | 5.522M |
| September 28, 2026 | 5.305M |
| September 25, 2026 | 5.059M |
| September 24, 2026 | 4.730M |
| September 23, 2026 | 3.822M |
| September 22, 2026 | 3.331M |
| September 21, 2026 | 2.011M |
| September 18, 2026 | 1.888M |
| September 17, 2026 | 1.842M |
| September 16, 2026 | 1.838M |
| September 15, 2026 | 1.795M |
| September 14, 2026 | 1.754M |
| September 11, 2026 | 1.755M |
| September 10, 2026 | 1.798M |
| September 09, 2026 | 1.838M |
| September 08, 2026 | 1.847M |
| September 04, 2026 | 1.848M |
| September 03, 2026 | 1.863M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.924M |
| September 01, 2026 | 1.917M |
| August 31, 2026 | 1.920M |
| August 28, 2026 | 1.925M |
| August 27, 2026 | 1.910M |
| August 26, 2026 | 1.887M |
| August 25, 2026 | 1.890M |
| August 24, 2026 | 1.865M |
| August 21, 2026 | 1.873M |
| August 20, 2026 | 1.895M |
| August 19, 2026 | 1.897M |
| August 18, 2026 | 1.919M |
| August 17, 2026 | 2.024M |
| August 14, 2026 | 2.044M |
| August 13, 2026 | 2.088M |
| August 12, 2026 | 2.068M |
| August 11, 2026 | 2.122M |
| August 10, 2026 | 2.185M |
| August 07, 2026 | 2.257M |
| August 06, 2026 | 2.355M |
| August 05, 2026 | 2.497M |
| August 04, 2026 | 2.639M |
| August 03, 2026 | 2.693M |
| July 31, 2026 | 2.753M |
| July 30, 2026 | 2.754M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.013M |
| Eli Lilly & Co. | 2.348M |
| Regeneron Pharmaceuticals, Inc. | 720681.1 |
| Amgen, Inc. | 2.956M |
| Ironwood Pharmaceuticals, Inc. | 2.012M |